Saltar al contenido
Merck
  • Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics.

Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics.

Molecular pharmacology (2017-01-15)
Ni Li, Xiao Wang, Yanni Xu, Yuan Lin, Ningyu Zhu, Peng Liu, Duo Lu, Shuyi Si
RESUMEN

Activation of liver X receptor (LXR) is associated with cholesterol metabolism and anti-inflammatory processes, which makes it beneficial to antiatherosclerosis therapy. Nevertheless, existing agonists that target LXR, for example TO901317, are related to unwanted side effects. In the present study, using a screening method we identified IMB-808, which displayed potent dual LXR

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Eppendorf® Thermomixer Compact, with 1.5 mL block, AC/DC input 115 V AC
Sigma-Aldrich
IMB-808, ≥98% (HPLC)